Am J Physiol Cell Physiol Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 292: C909-C918, 2007. First published September 27, 2006; doi:10.1152/ajpcell.00265.2006
0363-6143/07 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Figures and Table
Right arrow All Versions of this Article:
292/2/C909    most recent
00265.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stewart, A. K.
Right arrow Articles by Alper, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stewart, A. K.
Right arrow Articles by Alper, S. L.

CELLULAR METABOLISM

Transmembrane domain histidines contribute to regulation of AE2-mediated anion exchange by pH

A. K. Stewart,1,2 C. E. Kurschat,1 D. Burns,2 N. Banger,2 R. D. Vaughan-Jones,2 and S. L. Alper1

1Molecular and Vascular Medicine Unit and Renal Unit, Beth Israel Deaconess Medical Center, and Department of Medicine, Harvard Medical School, Boston, Massachusetts; and 2Burdon Sanderson Cardiac Science Centre, University Laboratory of Physiology, University of Oxford, Oxford, United Kingdom

Submitted 12 May 2006 ; accepted in final form 17 September 2006


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Activity of the AE2/SLC4A2 anion exchanger is modulated acutely by pH, influencing the transporter's role in regulation of intracellular pH (pHi) and epithelial solute transport. In Xenopus oocytes, heterologous AE2-mediated Cl/Cl and Cl/HCO3 exchange are inhibited by acid pHi or extracellular pH (pHo). We have investigated the importance to pH sensitivity of the eight histidine (His) residues within the AE2 COOH-terminal transmembrane domain (TMD). Wild-type mouse AE2-mediated Cl/Cl exchange, measured as DIDS-sensitive 36Cl efflux from Xenopus oocytes, was experimentally altered by varying pHi at constant pHo or varying pHo. Pretreatment of oocytes with the His modifier diethylpyrocarbonate (DEPC) reduced basal 36Cl efflux at pHo 7.4 and acid shifted the pHo vs. activity profile of wild-type AE2, suggesting that His residues might be involved in pH sensing. Single His mutants of AE2 were generated and expressed in oocytes. Although mutation of H1029 to Ala severely reduced transport and surface expression, other individual His mutants exhibited wild-type or near-wild-type levels of Cl transport activity with retention of pHo sensitivity. In contrast to the effects of DEPC on wild-type AE2, pHo sensitivity was significantly alkaline shifted for mutants H1144Y and H1145A and the triple mutants H846/H849/H1145A and H846/H849/H1160A. Although all functional mutants retained sensitivity to pHi, pHi sensitivity was enhanced for AE2 H1145A. The simultaneous mutation of five or more His residues, however, greatly decreased basal AE2 activity, consistent with the inhibitory effects of DEPC modification. The results show that multiple TMD His residues contribute to basal AE2 activity and its sensitivity to pHi and pHo.

pH regulation; histidine residues; Cl/HCO3 exchange


THE SLC4 BICARBONATE TRANSPORTER gene superfamily includes the anion exchanger gene family of Na+-independent Cl/HCO3 exchangers, AE1, AE2, and AE3. In mammalian cells, these anion exchangers are involved in the control of intracellular Cl, pH, and cell volume (2). The anion exchanger polypeptides share a highly conserved COOH-terminal transmembrane domain (TMD) of ~500 amino acids (aa) with a short COOH-terminal cytoplasmic tail. The TMD is preceded by a less extensively conserved ~400-aa (AE1) to ~700-aa (AE2 and AE3) NH2-terminal cytoplasmic tail (1). The COOH-terminal TMD can mediate anion exchange in the absence of the NH2-terminal cytoplasmic domain (12, 21, 37), but the physiological regulation of AE2 transport activity by pH requires the NH2-terminal cytoplasmic domain.

The anion exchanger polypeptides are expressed in tissue- and cell-specific patterns and differ in their acute response to a change of pH. Structural elements contributing to this pH sensitivity have been localized to the COOH TMD and NH2-terminal cytoplasmic domain (37, 46). AE1-mediated Cl/HCO3 and Cl/Cl exchange in erythrocytes (10) and Xenopus oocytes exhibits a broad pH vs. activity profile (17, 46). In contrast, Na+-independent Cl/HCO3 exchange in nonerythroid cells in culture is often characterized by strong pH sensitivity (24, 35) and is most likely mediated by AE2 and AE3 gene products and/or by polypeptides of the SLC26 gene family. A high sensitivity to intracellular pH (pHi) and/or extracellular pH (pHo) has been observed for recombinant AE2 and AE3 expressed in tissue culture cells (19, 23) and Xenopus oocytes (37, 46). AE2–/– mice are achlorhydric and fail to survive weaning (11). AE3–/– mice display enhanced susceptibility to pharmacologically induced seizures (14).

Structure-function studies have localized to the AE2 TMD a putative "pH sensor" that confers sensitivity of the anion transporter to changes in pHo and pHi (37, 46). The pHo at which AE2 activity is half-maximal [pHo(50)] is ~6.9. Truncation of the NH2-terminal cytoplasmic domain acid shifts pHo(50) by ~0.7 pH unit and abolishes pHi sensitivity (37). We have defined two noncontiguous regions of the NH2-terminal cytoplasmic domain, the highly conserved aa 336–360 and the less well conserved aa 391–410, in which mutations alter or abolish pH sensitivity (39). However, residues of the AE2 TMD whose mutation alters AE2 pH sensitivity have not been reported, and the molecular identity of the pH sensor(s) in the AE2 COOH-terminal TMD remains unknown.

With their imidazole side chain pKa of ~6.0 as the free amino acid, AE2 histidine (His) residues are strong a priori candidate pH sensors within the TMD (29). In contrast to the established role of His residues in conferring pH sensitivity on various ion channels (5, 6), the potential role of TMD His residues in the regulation of acid/base transporters is less well understood. For example, TMD His residues are not essential for cation transport through the ubiquitous eukaryotic Na+/H+ exchanger NHE1, but their mutation alters the inhibitory potency of amiloride (42). In contrast, mutation of a single His residue in the prokaryotic Sod2 Na+/H+ exchanger of S. pombe impairs proton translocation (43). Juxtamembranous His residues of the NHE3 COOH-terminal cytoplasmic domain have also been implicated in sustaining basal transport activity and its regulation by pHi (4), but a role for His residues in the TMD has not been reported. Four of the five TMD His residues in mouse AE1 are essential for basal transport activity (13, 32), and, although all five are conserved among the eight His residues of the mouse AE2 TMD, the influence of those His residues on AE2 pH sensitivity has not been studied.

In the present work, we have investigated the role of TMD His residues in AE2-mediated Cl/anion exchange and its regulation by pHo and pHi. Through functional assay of AE2 polypeptides into which we have introduced mutations of individual and multiple His residues, we have determined their contributions to basal anion flux and polypeptide accumulation and to the pH sensitivity of AE2-mediated anion transport.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Materials. Na36Cl was purchased from ICN (Irvine, CA). The other chemical reagents, which were of analytic grade, were obtained from Sigma (St. Louis, MO), Calbiochem (San Diego, CA), or Fluka (Milwaukee, WI). Restriction enzymes and T4 DNA ligase were obtained from New England BioLabs (Beverly, MA), and Taq DNA polymerase and dNTPs from Promega (Madison, WI) or Invitrogen (Paisley, UK).

Construction of AE2 His mutants. Murine AE2a encoded in plasmid p{Delta}X (46) was used as template for PCR. AE2a His substitution mutants were constructed by a four-primer PCR method as described elsewhere (15, 46). Integrity of PCR products and ligation junctions was confirmed by DNA sequencing of both strands. The AE2 mutant H846A/H849A constructed by the same method was cut with StuI and BsrGI and then ligated into the appropriate AE2 His mutant backbone (H1144Y, H1145A, or H1160A) to generate three-His mutants. The five- or six-His mutants were constructed from the appropriate three-His mutant templates by four-primer PCR or ligation of StuI/BsrGI insert fragments containing the desired His mutations into the similarly restricted three-His mutant backbone. The wild-type AE2a-green fluorescent protein (GFP) fusion protein with a COOH-terminal GFP was constructed by four-primer PCR. COOH-terminal GFP fusions of AE2 mutants were then generated by ligation of complementary restriction fragments. Oligonucleotide primers were obtained from Biosynthesis (Woodlands, TX); primer sequences are available on request.

cRNA expression in Xenopus oocytes. Mature female Xenopus (Xenopus One, Madison, WI) were maintained and subjected to partial ovariectomy as described (46). Stage V–VI oocytes were manually defolliculated after incubation of ovarian fragments with 2 mg/ml collagenase A (Boehringer Mannheim, Indianapolis, IN) for 60 min in ND-96 solution containing 50 ng/ml gentamicin and 2.5 mM sodium pyruvate. Oocytes were injected on the same day with cRNA or water in a volume of 50 nl. Capped cRNA was transcribed from linearized cDNA templates with the T7 MEGAscript kit (Ambion, Austin, TX) and resuspended in diethylpyrocarbonate (DEPC)-treated water. RNA integrity was confirmed by agarose gel electrophoresis in formaldehyde, and RNA concentration was estimated by absorbance at 260 nm. cRNA-injected oocytes were then maintained for 2–6 days at 19°C until they were used for functional assay (see below).

36Cl efflux assay. Individual oocytes in Cl-free ND-96 solution [in mM: 96 sodium isethionate, 2 potassium gluconate, 1.8 calcium gluconate, 1 magnesium gluconate, and 5 HEPES (pH 7.4)] were injected with 50 nl of 260 mM Na36Cl (10,000–12,000 cpm). After 5–10 min of recovery in the same medium, the efflux assay was initiated by transfer of individual oocytes to 1 ml of ND-96 efflux solution containing (in mM) 96 NaCl, 2 KCl, 1.8 CaCl2, 1 MgCl2, and 5 HEPES in 6-ml borosilicate glass tubes. At 3-min intervals, 0.95 ml of this efflux solution was removed for scintillation counting and replaced with an equal volume of fresh efflux solution. After completion of the assay with a final efflux period in the presence of the anion transport inhibitor DIDS (200 µM), each oocyte was lysed in 100 µl of 2% SDS. 36Cl was quantitated as counts per minute (cpm) over 3–5 min, such that 2 SDs <5% of the sample mean.

Experimental data were plotted as ln (%cpm remaining in the oocyte) vs. time. 36Cl efflux rate constants were measured from linear fits to data from the last three time points sampled for each experimental condition. All single time-point values for 36Cl efflux from AE2 cRNA-injected oocytes into Cl-containing medium exceeded 150 cpm. Efflux values for water-injected oocytes (30–90 cpm) were indistinguishable from those for AE2 cRNA-injected oocytes in the presence of 200 µM DIDS and exceeded machine background (10–25 cpm). Within each experiment, water- and AE2 cRNA-injected oocytes from the same frog were subjected to parallel measurements. On each experimental day, bath Cl-dependent 36Cl efflux activity of the tested mutant AE2 polypeptides was compared at pHo 7.4 with wild-type AE2 activity ("basal anion exchange activity"). AE2 mutants exhibiting low or absent transport activity at pHo 7.4 are described in RESULTS as "low-expression" polypeptides. Each AE2 mutant was tested in oocytes from at least two, and usually three frogs (efflux data are summarized in Supplemental Table 1 in the online version of this article). The weak-acid salt sodium butyrate was added to flux media as an equimolar substitution for NaCl. Some oocytes were treated for the indicated times with 0.5 or 5.0 mM DEPC, and 10 or 50 mM hydroxylamine was added in several experiments after removal of DEPC.

pHo dependence of anion exchanger-mediated 36Cl efflux. Individual oocytes initially maintained in Cl-free solution at pHo 7.4 were exposed sequentially to ND-96 buffered to pH 5.0 or 6.0 with 5 mM MES and then to ND-96 buffered to pH 7.0, 8.0, or 8.5 with 5 mM HEPES before addition of 200 µM DIDS to terminate the assay and confirm pharmacospecificiy of the 36Cl efflux (32, 37). Rate constants measured at each pHo in individual oocytes expressing wild-type AE2 or the AE2 mutant were fit (Sigma Plot) to the following first-order logistic sigmoid equation

Formula 1(1)
where {nu} is the AE2-mediated Cl efflux rate constant, Vmax is the maximum AE2-mediated Cl efflux rate constant, x is pHo at which the rate constant was measured, K is pHo(50) (i.e., pHo at which {nu} is half-maximal), and d is the y-axis point of intersection. Any value of d > 0 leads to an underestimate of the degree of acid shift of pHo(50) for the particular AE2 mutant compared with the wild-type AE2 pHo(50).

Rate constants for each mutant were normalized to the fit parameter Vmax calculated for each individual oocyte (100%), and the normalized data were fit to Eq. 1. The pHo dependence of wild-type AE2-mediated 36Cl efflux did not differ when the experiment was performed with the order of pHo change reversed or randomized (38). pHo dependence was also unchanged when pHi was clamped during pHo variation by simultaneous alteration of butyrate concentration in the bath (38) [see Supplemental Table 1 for pHo(50) data for wild-type and mutant AE2 polypeptides].

pHi dependence of AE-mediated 36Cl efflux. pHi was varied at constant pHo by preincubation of 36Cl-injected oocytes for 30 min before the start of the experiment in pH 7.4 Cl-free solution containing 40 mM sodium butyrate. Under these conditions, pHi falls by ~0.5 pH unit. 36Cl efflux was initiated by transfer of oocytes to Cl-containing solution in the continued presence of butyrate. The oocytes were then transferred to efflux medium containing Cl but lacking weak acid. In these conditions, pHi increases 0.50 ± 0.03 unit after butyrate removal, with a time constant of ~6 min, and butyrate is neither an inhibitor of nor a substrate for AE2 (37). 36Cl efflux rate constants were normalized as the ratio of the efflux activity in the presence of 40 mM butyrate to that in the absence of butyrate at constant pHo 7.4 (see Supplemental Table 1 for summary of normalized 36Cl efflux rate constants for wild-type and mutant AE2 polypeptides).

Immunoblot analysis of mouse AE2 polypeptide in Xenopus oocytes. Ten oocytes previously injected with a single cRNA were suspended at 4°C in oocyte lysis buffer (10 µl/oocyte) containing 1% Triton X-100, Complete protease inhibitor (Roche Diagnostics, Indianapolis, IN), 50 mM Tris·HCl (pH 7.4), 150 mM NaCl, and 1 mM EDTA. After the sample was shaken vigorously for 30 min at 4°C, the extract was centrifuged for 10 min at 4°C in a microcentrifuge. Clarified total oocyte lysate was fractionated by SDS-PAGE (8% gels), transferred to nitrocellulose, developed with affinity-purified rabbit polyclonal antibody to mouse AE2 COOH-terminal aa 1224–1237 (46), and visualized on Kodak XB-1 film by chemiluminescence (Perkin Elmer Life Sciences, Boston, MA).

Confocal fluorescence microscopy. At least 10 oocytes expressing each GFP fusion construct to be tested were fixed overnight in PBS containing 3% paraformaldehyde, washed three times in PBS, incubated overnight in 30% sucrose in PBS, and then mounted in OCT compound and frozen in liquid N2. Cryosections (20 µm) were imaged with a laser scanning confocal microscope (model MRC1024, Bio-Rad). Representative sections imaged at uniform laser intensity and filter settings were compiled in Microsoft PowerPoint.

Statistical analysis. Values are means ± SE. Values for individual mutants and multiple groups of mutants were compared with that of wild-type AE2 by Dunnett's two-way t-test. The level of significance was taken as P < 0.05.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
DEPC inhibits AE2-mediated anion transport. We previously showed that the AE2 COOH-terminal TMD mediates anion exchange in the absence of nearly the entire NH2-terminal cytoplasmic domain (37). The AE2 TMD includes eight His residues, only three of which are not conserved in the closely related but pH-insensitive AE1 TMD. We tested the importance of His residues in basal AE2-mediated 36Cl efflux by exposing the oocytes to the moderately specific His-modifying agent DEPC (Fig. 1A). Basal rates of 36Cl efflux from individual oocytes expressing wild-type AE2 were measured at pH 7.4 (period a) and exposed for 12 min to 5 mM DEPC at pHo 6.0 (period b); then DEPC was washed out at pH 7.4 in the absence of Cl (period c) and Cl was restored (period d). The assay was terminated with addition of the anion transport inhibitor DIDS (200 µM; period e). In the absence of DEPC, reduction of pHo from 7.4 to 6.0 decreased wild-type AE2-mediated 36Cl efflux to 10–15% of the control rate, with restoration of efflux to ~85% of the initial rate on return to pHo 7.4. In the presence of 5 mM DEPC at pH 6.0, AE2-mediated 36Cl efflux was inhibited by ~98% and recovered to only ~20% of the initial rate after pHo was restored to 7.4 (Fig. 1B).


Figure 1
View larger version (25K):
[in this window]
[in a new window]

 
Fig. 1. Diethylpyrocarbonate (DEPC) modulates regulation of anion exchanger (AE2)-mediated Cl transport. A: time course of 36Cl efflux from 2 representative oocytes expressing wild-type AE2 and sequentially exposed to pHo 7.4 (a) and then pHo 6.0 in the presence or absence of 5.0 mM DEPC (b) followed by return to pHo 7.4 in the absence (c) and then the presence of Cl (d) and, finally, addition of 200 µM DIDS (e). B: normalized rate constants (±SE) of AE2-mediated 36Cl efflux during exposure to DEPC at the indicated concentrations at pHo 6.0 or pHo 7.4 (black bars, period b in A) and after DEPC removal and subsequent recovery at pHo 7.4 (gray bars, period d in A); (n) oocytes from two or more frogs. C: regulation by pHo of 36Cl efflux from oocytes expressing AE2 after pretreatment without (filled circles) or with (open circles) 5 mM DEPC. Normalized rate constants are means ± SE; curves were fit to data as described in MATERIALS AND METHODS. D: pHo(50) values of (n) oocytes expressing wild-type AE2 pretreated with or without 5 mM DEPC, as calculated from fits of normalized 36Cl efflux rate constant vs. pHo as in B (mean ± SE). *P < 0.005.

 
Erythroid AE1-mediated anion transport was earlier shown to be inhibited by DEPC partially at pHo 6.0 and maximally at pHo 7.4, effects attributed to bath pH-induced changes in red cell pHi (24). We therefore compared the pH and concentration dependence of DEPC inhibition of Cl transport mediated by AE2. AE2-mediated Cl transport was completely inhibited by 0.5 or 5.0 mM DEPC at pHo 6.0, whereas oocytes treated with 0.5 mM DEPC at pHo 7.4 retained ~20% of residual activity (Fig. 1B). The greater inhibition at pHo 6.0 likely reflects combined inhibitory effects of acidic pHo and DEPC. Recovery of AE2-mediated Cl transport on DEPC washout was independent of pHo during DEPC exposure but was proportional to DEPC concentration. Recovery of AE2 function was 75–80% after exposure to 0.5 mM DEPC but only 10–20% after exposure to 5 mM DEPC. We next tested whether hydroxylamine, a reagent that removes N-carbethoxy groups from DEPC-modified His (29), could reverse the effects of DEPC modification of AE2. However, the persistent inhibition after removal of 5 mM DEPC was not reversed by subsequent 12-min exposure of oocytes to 10 or 50 mM hydroxylamine (n = 12 and 4, respectively; data not shown).

DEPC acid-shifts pHo sensitivity of AE2-mediated anion transport. Oocytes expressing wild-type AE2 were pretreated with 5 mM DEPC for 10 min at pHo 6.0 before assay of pHo-dependent 36Cl efflux (see MATERIALS AND METHODS). The normalized efflux data revealed an apparently acid-shifted pHo sensitivity of anion transport (Fig. 1C). In contrast to the control wild-type AE2 pHo(50) of 6.91 ± 0.05, DEPC-treated AE2 exhibited a pHo(50) of 5.92 ± 0.22 (P < 0.005; Fig. 1D). As these data suggest a possible role for TMD His residues in setting the pHo sensitivity of AE2, we studied AE2 mutants with individual amino acid substitutions in each of the eight His residues of the TMD, as well as in eight multiple-His mutants of AE2.

TMD His residues are important for basal levels of AE2-mediated Cl transport. The schematic diagram in Fig. 2A shows the locations of the eight His residues within the AE2 TMD, mapped according to the topographical models of AE1 proposed by Zhu et al. (47) and Fujinaga et al. (9). Figure 2B shows that AE2 polypeptide levels in oocytes expressing wild-type or mutant cRNAs did not consistently correlate with basal transport activity at pHo 7.4 (Fig. 2C). In particular, AE2 mutants H1029A and H1060A showed similar low levels of 36Cl efflux, despite very different levels of protein accumulation. However, the six other single-His mutants displayed sufficient 36Cl efflux activity to allow analysis of their sensitivities to pHi and pHo. The low activity of AE2 mutant H1060A contrasted with the near-wild-type activity of mutant H1060E. The low activity of AE2 H1144A contrasted with the ~50% wild-type activity of mutant H1144Y, substituting of the Tyr residue present in the corresponding position of the relatively pH-insensitive AE1 (Fig. 2C).


Figure 2
View larger version (35K):
[in this window]
[in a new window]

 
Fig. 2. Individual His mutations within AE2 transmembrane domain (TMD) reveals key His residues involved in Cl transport. A: putative locations of the 8 His residues of the AE2 TMD; topography proposed by Zhu et al. (47) based on Cys accessibility mutagenesis (46). AE2 His residues boldface are nonconserved in AE1. B: oocyte expression of wild-type and mutant AE2 polypeptides as detected by immunoblot of Triton X-100 lysates. C: 36Cl efflux rate constants measured at pHo 7.4 in oocytes expressing wild-type AE2 or TMD His mutants (means ± SE). *P < 0.05. D: representative confocal fluorescence images of cryosections from oocytes previously injected with water or with cRNA encoding WT or mutant AE2-GP-fusion protein. Scale bar, 180 µm.

 
Oocyte surface expression of low-activity AE2 mutants was determined with the corresponding COOH-terminal GFP fusion proteins (Fig. 2D), since wild-type AE2-GFP exhibited 36Cl efflux rate constants comparable to that of native wild-type AE2 (not shown). The low expression and activity of AE2 H1029A were corroborated by low GFP fluorescence inside the oocyte and at or near the oocyte surface. The low activity of AE2 H1060A, despite high polypeptide expression, was accompanied by substantial expression at or near the oocyte surface, approximately comparable to that of the highly active AE2 mutant H1060E. Thus, whereas His modification at AE2 H1029 impairs polypeptide accumulation, His modification at AE2 H1060 can modify functional activity at or near the oocyte surface. By this criterion, at least some His residues are important for basal levels of AE2-mediated Cl transport.

The active His substitution mutants of AE2 allowed a test of the hypothesis that inhibition of AE2 by DEPC might be mediated entirely, or in large part, by modification of a single His residue of the AE2 TMD. As shown in Fig. 3A, anion transport by wild-type AE2 and AE2 H1160A was nearly completely inhibited by exposure to 5 mM DEPC at pHo 6.0, with only ~20% recovery after DEPC removal at pHo 7.4. (Initial DEPC exposure at pHo 7.4 produced similar degrees of inhibition and recovery, as shown for AE2 H1160A in Supplemental Fig. 1C). In contrast, the AE2 mutant H1144Y was the only tested polypeptide that showed substantially increased post-DEPC recovery at pHo 7.4 (Fig. 3B). This enhanced recovery was also evident after DEPC exposure at pHo 7.4 and in the setting of a triple-His mutant (Fig. 3C; see Supplemental Fig. 1B). These data thus suggest that the nonconserved H1144 of AE2 is an important participant in irreversible AE2 inhibition by DEPC, although modification of this single-His residue does not mediate the full effect of DEPC.


Figure 3
View larger version (16K):
[in this window]
[in a new window]

 
Fig. 3. Mutagenesis identifies key His residues of the AE2 TMD involved in inhibition by DEPC. A: 36Cl efflux time course for representative oocytes expressing wt AE2, AE2 H1144Y, or AE2 H1160A measured during sequential periods at pHo 7.4 (a), at pHo 6.0 in the presence of 5 mM DEPC (b), and at pHo 7.4 in the absence (c) and subsequent presence of Cl (d), then completed by addition of 200 µM DIDS (e). B: normalized 36Cl efflux rate constants (means ± SE), measured at pHo 7.4 after recovery from prior DEPC exposure at pHo 6.0, in (n) oocytes expressing WT AE2 or the indicated His mutants. L. E., low expression. C: normalized 36Cl efflux rate constants (means ± SE), measured at pHo 7.4 after recovery from prior DEPC exposure at pHo 7.4, in (n) oocytes expressing wt or mutant AE2. The gray bars and * in B and C indicate significant post-DEPC recovery of function compared with wt AE2 (P < 0.0005).

 
Extracellular Zn2+ (1 mM), which targets His and other residues, inhibited wild-type AE2 by ~45% but was without effect on wild-type AE1. This selective AE2 inhibition also appeared to be mediated in part by H1144, since the AE2 mutant H1144Y was inhibited to a lesser degree by 1 mM Zn2+ (as was the triple mutant H846A/H849A/H1144Y; see Supplemental Fig. 3). These data reinforce the importance of H1144 in regulating AE2 activity.

His residues of the AE2 TMD are involved in regulation of AE2 by pH. We showed previously that His residues of the AE2 NH2-terminal cytoplasmic domain are important for pH sensitivity (39). Figure 4A profiles normalized 36Cl efflux activity as a function of pHo for wild-type AE2 and the H1144Y mutant. The alkaline-shifted pHo(50) for H1144Y (7.15 ± 0.08, n = 15) was significantly different from that of wild-type AE2 (6.82 ± 0.04, n = 62, P < 0.005). Figure 4B summarizes pHo(50) values measured for several AE2 His substitution mutants. In addition to AE2 H1144Y, the mutant H1145A also exhibited a modestly alkaline-shifted pHo(50) (P < 0.005). The apparently alkaline-shifted pHo(50) values of AE2 mutants H846A and H849A did not reach statistical significance (Fig. 4B).


Figure 4
View larger version (28K):
[in this window]
[in a new window]

 
Fig. 4. Mutagenesis of individual His residues within AE2 COOH-terminal TMD modulates regulation by pH. A: regulation by pHo of normalized 36Cl efflux from oocytes expressing wild-type AE2 or AE2 H1144Y. Values are means ± SE. B: pHo(50) for His mutants of AE2 COOH-terminal TMD (means ± SE). C: time course of 36Cl efflux from representative individual oocytes expressing WT AE2 or AE2 mutants H846A, H1029A, or H1145A during the presence and subsequent removal of bath butyrate (40 mM) to change pHi at constant pHo and, concluded by the addition of 200 µM DIDS. D: normalized rate constants of 36Cl efflux rate constants (±SE) in the presence of bath butyrate for oocytes expressing wild-type AE2 or mutants. Values are means ± SE of number of oocytes in parentheses. Shaded bars and * in B and D indicate significant difference (P < 0.0005) from wild-type AE2.

 
We next tested the hypothesis that individual His residues of the TMD influence the pHi sensitivity of AE2. Bath addition and subsequent removal of the weak acid butyrate was used to decrease and then increase oocyte pHi (37). Figure 4C shows the 36Cl efflux time course of oocytes expressing wild-type AE2 or the AE2 mutants H846A, H1029A, and H1145A. The mutants were inhibited at low pHi (in the presence of butyrate) and subsequently stimulated (on butyrate removal) by a rise of pHi. Figure 4D shows that all active His mutants retained pHi sensitivity. Notably, the AE2 mutant H1145A exhibited a uniquely enhanced inhibition by acidic pHi (P < 0.005).

We previously demonstrated that double mutations of selected residues in the AE2 NH2-terminal cytoplasmic domain can have effects on the pH sensitivity of AE2 that are different from the effects of their component single-mutant counterparts (39). We therefore tested the effect of mutating multiple-His residues in the TMD, as schematized in Fig. 5A. Figure 5B shows that mutant polypeptides containing three or fewer His substitutions retained 36Cl efflux activity at pHo 7.4 sufficient for analysis of pH sensitivity (mutants His2, His3a, His3b, and His3c). In contrast, mutants containing five or more His substitutions exhibited very low anion transport activity, which precluded assessment of pH sensitivity (mutants His5a, His5b, His6a, and His6b). Among the multiple-His mutants that exhibited sufficient basal activity, the double mutant H846A/H849A (His2; Fig. 5C) displayed a near-wild-type pHo dependence (P = 0.07), whereas the triple mutants H846A/H849A/H1145A (His3b) and H846A/H849A/H1160A (His3c) exhibited alkaline-shifted pHo(50) values of 7.29 ± 0.09 and 7.30 ± 0.09, respectively (each n = 22, P < 0.02 compared with wild-type AE2). Figure 5D summarizes the pHo(50) values derived from experiments similar to those shown in Fig. 5C. AE2 residues H846 and H849 are likely to have contributed to the alkaline-shifted pHo(50) of mutant His3c, inasmuch as the pHo(50) of mutant H1160A did not differ from the wild-type value (Fig. 4B). Multiple-His mutations also affected sensitivity to pHi. Thus inhibition by low pHi was enhanced in AE2 triple mutants His3b and His3c (P < 0.02), although the mutants His3a and His2 retained wild-type sensitivity (see Supplemental Fig. 2C).


Figure 5
View larger version (24K):
[in this window]
[in a new window]

 
Fig. 5. Effect of mutagenesis of multiple His residues within the AE2 COOH-terminal TMD on AE2 regulation by pHo. A: Location of the 7 individual AE2 TMD His residues mutated in combination (as indicated by x). B: 36Cl efflux rate constants measured at pHo 7.4 in (n) oocytes expressing wild-type AE2a or the indicated AE2 TMD multi-His mutants (mean ± SE). C: regulation by pHo of normalized 36Cl efflux from oocytes expressing wild-type AE2a or the mutants His2, His3c, or His3b. Values are means ± SE. D: pHo(50) values for the indicated His mutants (means ± SE). Gray bars and * indicate significant difference from wt AE2 (P < 0.01).

 
Do His residues of the AE2 TMD interact with other TMD residues to mediate sensitivity to DIDS and to pH? Muller-Berger et al. (32) suggested that mouse AE1 H752 (corresponding to AE2 H1060) is allosterically coupled to K558, part of the AE1 DIDS-binding site corresponding to AE2 K838. We therefore tested DIDS sensitivity of the AE2 mutant H1060E. Figure 6A shows that wild-type AE2-mediated 36Cl efflux was inhibited ~80–85% by 200 µM DIDS in the presence or absence of extracellular Cl. In contrast, AE2 H1060E-mediated 36Cl efflux was inhibited by only 20% (n = 15, P < 0.05) in the presence of extracellular Cl (although, in the absence of Cl, inhibition resembled the wild-type phenotype). This finding is consistent with an influence of AE2 H1060 on the DIDS isothiocyanate covalent reaction site K838, reflected in an apparent decrease in inhibitory potency of DIDS.


Figure 6
View larger version (33K):
[in this window]
[in a new window]

 
Fig. 6. Test of a predicted intra-membrane interaction in regulation of AE2-mediated Cl transport by pHi. A: 36Cl efflux rate constants measured at pHo 7.4 in oocytes expressing wild-type AE2a or H1060E. Subsequent inhibition by 200 µM DIDS was measured in the presence (light gray bar) and absence (dark gray bar) of extracellular Cl. B: 36Cl efflux rate constants measured at pHo 7.4 in oocytes expressing wild-type AE2a, H1060E, E1007H and the double mutant H1060E/E1007H. C: 36Cl efflux rate constants in the presence (black bars) and subsequent absence of bath butyrate (gray bars), reflecting regulation by pHi at constant pHo. Values in A–C are means ± SE for (n) oocytes. D: oocyte expression of wt and the indicated mutant AE2 polypeptides as detected by immunoblot of Triton X-100 lysates. E: representative confocal fluorescence images of cryosections from oocytes previously injected with water or with cRNA encoding the indicated AE2-GFP fusion protein. Scale bar, 180 µm.

 
Muller-Berger et al. (31) also observed acid-shifted pHo sensitivity of Cl efflux as a result of substitutions in mouse AE1 residues H752 and E699 (corresponding to mouse AE2 H1060 and E1007). This observation led them to propose that a hydrogen bond between the side chains of these two TMD residues is required for pH sensitivity.

We tested this hypothesis for AE2. The mutant H1060E retained wild-type 36Cl efflux activity at pHo 7.4 (Fig. 6B) and wild-type pHi sensitivity (Fig. 6C), in contrast to the loss-of-function mutant H1060A (Fig. 3). Figure 6B also shows that the AE2 mutant E1007H exhibited loss of function (as did also the AE2 mutants E1007K and E1007C, not shown). The AE2 double mutant E1007H/H1060E, rather than rescuing wild-type function, was inactive (Fig. 6B) and not further stimulated by changes in pHi (Fig. 6C). These changes were not explained by reduced accumulation of mutant polypeptides (Fig. 6D) or by low surface expression of the inactive mutant E1007H (Fig. 6E). The corresponding AE1 single and double mutants are well expressed in oocytes (31), and the AE2 single mutants E1007Q, E1007K, and E1007D are also abundantly expressed in HEK 293 cells (36) and oocytes (unpublished data). Thus, although reduced surface expression of the H1060E/E1007H double mutant remains a possibility, these results are consistent with absence in the AE2 TMD of an interhelical functional interaction corresponding to that proposed between H752 and E699 of mouse AE1 (31).


    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The molecular mechanism underlying acute pH-dependent regulation of anion exchange by AE2/SLC4A2 involves the NH2-terminal (cytoplasmic) and COOH-terminal (transmembrane) domains of the protein (46). Individual amino acid residues of the cytoplasmic domain important for this regulation have been identified (38, 39), but the contribution of residues within the TMD has not previously been studied. The present work has examined the role of TMD His residues. The His-modifying agent DEPC, which likely modifies multiple His residues of AE2, has dual effects: attenuation of basal activity at pHo 7.4 and acid shift of the pHo-sensitivity of remaining transport activity. His mutagenesis also reveals that multiple His residues are required for basal activity and contribute to pH sensitivity of AE2. Mutation of individual TMD His residue H1029 prevents polypeptide accumulation and surface expression, whereas distinct substitutions at H1060 can preserve or severely attenuate transport activity, each with preserved surface expression. Mutation of other His residues, such as H1144 or H1145, alters the pH sensitivity of transport, whereas mutation of H1144 to Tyr reduces the inhibitory effects of DEPC or Zn2+. Simultaneous mutation of five or more His residues abolishes AE2 transport activity in oocytes.

Taken together, the data suggest that multiple His residues of the AE2 TMD contribute to the modulation of AE2 activity by pH.

DEPC sensitivity of AE2-mediated anion exchange suggests involvement of His residues. The His-modifying agent DEPC is commonly used to assess possible involvement of His residues in native or recombinant ion channel or transporter function and, in particular, their involvement in pH sensitivity. DEPC carboxyethylates the proton-titratable imidazole group of His in a pH-sensitive reaction (7, 29), and DEPC specificity for His modification has been claimed at pH 5.5–7.5 (3). We have shown that DEPC can reversibly inhibit AE2-mediated Cl transport in Xenopus oocytes, in contrast to its irreversible inhibition of kAE1 (Fig. 1B; see Supplemental Fig. 1A). DEPC treatment also results in an acid shift of the pHo(50) value of AE2-mediated Cl transport. These findings suggest that His residues are involved in the regulation of AE2 by pHo. DEPC (5 mM) is known to inhibit AE1-mediated Cl binding and anion transport by ~70% in resealed erythrocyte ghosts at pHo 6.0 and pHi 7.4 but has little or no effect when pHi and pHo are 6.0 (13, 18). Results with the former condition resemble data obtained for kAE1-mediated Cl transport in Xenopus oocytes at pHi ~7.25 and pHo 6.0 (see Supplemental Fig. 1A) (37, 46). Therefore, the DEPC inhibition of wild-type AE1 is consistent with previous studies.

DEPC also affects the activity of other solute transporters in a pH-dependent manner, purportedly by interfering with His residues. For example, DEPC inhibited NHE1 activity (42) and aquaporin 1-mediated water transport (33, 34) in Xenopus oocytes at pHo 6.0. In contrast, DEPC inhibition of the ClC-1 Cl channel was pHo independent between pHo 5.5 and 8.5 (22).

In the present work, AE2 differs from kAE1 in the extent and reversibility of inhibition by DEPC. These differences might be attributed to any of the three His residues of the AE2 TMD present in addition to the five TMD His residues also conserved in AE1. Inhibition of AE1 by DEPC has previously been attributed to modification of two separate His residues. Muller-Berger et al. (31) concluded from studies on murine erythroid AE1 expressed in oocytes that H752 (equivalent to H1060 in AE2) was the main site of DEPC action. In contrast, Jin et al. (20) concluded, on the basis of mass spectroscopic analysis of native human AE1 tryptic fragments from resealed red cell ghosts, that H834 (equivalent to H1160 in AE2) was the principal site of irreversible inhibition by DEPC. In the present study, DEPC inhibition and post-DEPC recovery at pHo 7.4 were indistinguishable for wild-type AE2 and for H1060E, H1160A, and His3c (Fig. 3, B and C). Mutation of the nonconserved residues H1136 and H1145 also failed to modify AE2 inhibition by DEPC (Fig. 3B). These data suggest that the different patterns of DEPC inhibition of AE2 and AE1 may arise, at least in part, from DEPC modification of the nonconserved AE2 H1144. This conclusion is strengthened by the difference in AE2 transport rate produced by mutation of H1144 to Ala or to the corresponding AE1 residue Tyr (Fig. 2C), despite equivalent levels of polypeptide accumulation (not shown). The reduced extent and increased reversibility of DEPC inhibition of mutant AE2 H1144Y may reflect reduced adduct formation with H1144Y, a reduced association constant, and/or an increased dissociation constant. Since DEPC inhibition of AE2 H1144Y is incompletely reversible, H1144 is not likely the sole target of DEPC in wild-type AE2.

DEPC may also affect residues H1029 and H1060, inasmuch as Ala substitution of the former decreased polypeptide accumulation and surface expression, whereas Ala substitution of the latter inhibited transport function, despite maintained surface expression (Fig. 2). Thus the properties of AE2 inhibition by DEPC are consistent with involvement of His residues in protein stability or folding, in the basal transport process, and in its regulation by pH.

Mutation of individual His residues can modify AE2 pH sensitivity. Protonation of His residues can inhibit ion transport, as in the case of the Kv1.4 channel (6), or can stimulate it, as for lens aquaporin 0 water channels (40) and the influenza M2 proton channel (16). Muller-Berger et al. (32) suggested that four conserved His residues are individually required for wild-type anion exchange activity of mouse AE1. Although the conserved AE2 residue H1029 may be critical for AE2 activity (Fig. 2C), individual mutation of the other seven His residues of the AE2 TMD retained partial or full Cl transport activity. However, combined mutation of five or more His residues in AE2 leads to loss of function (Fig. 5B). The region in AE1 corresponding to that encompassing AE2 residues H1144, H1145, and H1160 has been proposed, on the basis of scanning Cys accessibility studies, to adopt a reentrant loop structure (Fig. 2A) (47). In this AE1-derived model, AE2 H1136 resides at the extracellular side of the lipid bilayer and H1160 at the cytosolic side of the lipid bilayer. The adjacent AE2 residues H1144 and H1145 are situated such that they might be accessible to either side of the permeability barrier. Interestingly, mutation of mouse AE1 K832 and K835 (corresponding to AE2 M1140 and K1143) partially or completely inhibited anion transport (32). The results together show the importance of this distal TMD region and its His residues in anion transport and its regulation. These TMD His residues may combine their influence with that of AE2 His residues of the NH2-terminal cytoplasmic domain shown previously to contribute to pH regulation of AE2. The latter include an important contribution by H360 and more limited roles of H314 and H317 (39). In contrast, NH2-terminal cytoplasmic domain residues H78, H79, H81, H82, H423, and H449–H451 can be mutated individually or in combination (in the case of H78, H79, H81, and H82) without impact on AE2 function or regulation by pHi or pHo (unpublished data).

Whereas DEPC treatment induces an acid shift in the pHo(50) of wild-type-AE2, mutation of individual His residues within the AE2 TMD can induce an alkaline shift of pHo sensitivity. Thus the individual AE2 mutants H1144Y (in which Tyr is the corresponding AE1 residue) and H1145A each exhibited an increase in pHo(50) (Fig. 4B). In addition, AE2 H1145A exhibited enhanced inhibition in response to a fall of pHi (Fig. 4D). The altered regulatory properties of these mutants are consistent with accessibility of the proposed reentrant loop to extracellular and intracellular solute. Because the presence of Tyr in the AE1 position corresponding to AE2 H1144 does not suffice to confer AE2-like pHo sensitivity on AE1, but substitution of AE2 H1144 with Tyr does suffice for an alkaline-shifted pHo(50) of AE2, it is more likely that the absence of His, rather than the presence of Tyr, alters the AE2 pHo sensitivity phenotype.

Although the AE2 triple-mutant His3c (Fig. 5A) showed an alkaline-shifted pHo(50), the "component" mutants H1160A and His2 exhibited wild-type pHo sensitivity. Thus individual mutation of H1144 and H1145 can alter pHo sensitivity of AE2-mediated Cl transport, whereas mutation of H1160 [corresponding to human AE1 DEPC target H834 (20)] alters pHo sensitivity only in cooperation with Ala substitutions at H846 and H849. A similar result was shown for the enhanced pHi sensitivity of the multi-His mutants His3c and His5a, in which some of the component single-His mutants had previously shown wild-type pHi sensitivity. Multiple-His residues were also shown to comprise a Zn2+-binding site on the dopamine D2 receptor, whereas single-His mutations had no effect (26).

The above results suggest the involvement of multiple AE2 His residues in control of pHo and pHi sensitivity of anion transport, although not in a way predicted by the acid-shifted pHo(50) produced by DEPC treatment of AE2. The inability of hydroxylamine to reverse AE2 inhibition by DEPC suggests that the DEPC modification(s) responsible for inhibition was His imidazole ring cleavage following its bis-carbethoxylation (25). The contrast between the DEPC-induced acid shift in AE2 pHo(50) and the His substitution-induced alkaline shift in pHo(50) of AE2 may represent the different consequences to pH sensitivity of Ala substitution and of imidazole ring cleavage. It is also possible that DEPC treatment or mutation of individual or multiple His residues could alter the oligomeric structure or the interprotomeric interface of AE2 (45, 48), with possible consequences to regulatory properties and/or interaction with regulatory proteins. Alternatively, the acid-shifted pH-sensitivity of DEPC-treated wild-type AE2 may reflect a contribution of DEPC modification of non-His residues such as Cys, Tyr, Trp, or Lys (2729). Examples of pH sensitivity control by residues other than His include Lys and Leu in renal outer medullary K+ channels (8), glutamate in TRPV5 (44), and a combination of five non-His-charged residues in TASK2 (30).

Muller-Berger et al. (31) postulated that mouse AE1 sustains anion exchange at pH values inhibitory to AE2 function via hydrogen bonding between the protonated conserved AE1 residue H752 and (in a separate helix) the conserved E699, at or near the permeability barrier. However, the role of mouse AE1 E699 in anion translocation suggests that such postulated hydrogen bonding itself might be regulated during the transport cycle. Our test of this proposal in AE2 is consistent with the absence of functional interaction between the two corresponding residues, or with altered folding and/or stability of the double mutant AE2 polypeptide (Fig. 6). Muller-Berger et al. also noted rescue of the mouse AE1 loss-of-function mutant H852Q with the second site reversion mutation K558N. However, a corresponding interaction in AE2 could not be tested in the setting of near-normal function of the AE2 mutant H1160A (Fig. 2C).

In conclusion, we have found that some His residues of the AE2 COOH-terminal TMD are necessary for protein stability and maintenance of basal AE2 activity. We have also found that certain TMD His residues are important for the regulation of AE2 activity by pH. No single His residue, however, seems to function as a unique TMD pH sensor. Rather, the presence of multiple His residues within the TMD defines a range of pHi and pHo values within which physiological regulation of anion transport may occur. Proton titration of the residues may, for example, be necessary for coordinating appropriate interaction between the TMD and pH-sensitive regions of the cytoplasmic NH2-terminal portion of the AE2 protein (3739). The opposing shifts in pHo sensitivity of AE2 produced by DEPC treatment and by single- or multiple-His substitution mutations remain unexplained, but the possibility that DEPC exerts additional effects on non-His residues cannot be excluded. Thus, in contrast to some ion channels in which protonation/deprotonation of one or a few His residues suffices to mediate pH sensitivity, the present study highlights a more complex molecular anatomy governing the pH sensitivity of an acid/base transporter.


    FOOTNOTES
 

Address for reprint requests and other correspondence: S. L. Alper, Beth Israel Deaconess Medical Center, 330 Brookline Ave., E/RW763, Boston, MA 02215 (e-mail: salper{at}bidmc.harvard.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
1. Alper SL. The band 3-related anion exchanger (AE) gene family. Annu Rev Physiol 53: 549–564, 1991.[Web of Science][Medline]

2. Alper SL, Darman RB, Chernova MN, Dahl NK. The AE gene family of Cl/HCO3 exchangers. J Nephrol 15 Suppl 5: S41–S53, 2002.

3. Bhattacharyya DK, Bandyopadhyay U, Banerjee RK. Chemical and kinetic evidence for an essential histidine in horseradish peroxidase for iodide oxidation. J Biol Chem 267: 9800–9804, 1992.[Abstract/Free Full Text]

4. Cha B, Oh S, Shanmugaratnam J, Donowitz M, Yun CC. Two histidine residues in the juxta-membrane cytoplasmic domain of Na+/H+ exchanger isoform 3 (NHE3) determine the set point. J Membr Biol 191: 49–58, 2003.[CrossRef][Web of Science][Medline]

5. Clarke CE, Veale EL, Green PJ, Meadows HJ, Mathie A. Selective block of the human 2-P domain potassium channel, TASK-3, and the native leak potassium current, IKSO, by zinc. J Physiol 560: 51–62, 2004.[Abstract/Free Full Text]

6. Claydon TW, Makary SY, Dibb KM, Boyett MR. K+ activation of Kir3.1/Kir3.4 and Kv1.4 K+ channels is regulated by extracellular charges. Biophys J 87: 2407–2418, 2004.

7. Cousineau J, Meighen E. Chemical modification of bacterial luciferase with ethoxyformic anhydride: evidence for an essential histidyl residue. Biochemistry 15: 4992–5000, 1976.[CrossRef][Medline]

8. Fakler B, Schultz JH, Yang J, Schulte U, Brandle U, Zenner HP, Jan LY, Ruppersberg JP. Identification of a titratable lysine residue that determines sensitivity of kidney potassium channels (ROMK) to intracellular pH. EMBO J 15: 4093–4099, 1996.[Web of Science][Medline]

9. Fujinaga J, Tang XB, Casey JR. Topology of the membrane domain of human erythrocyte anion exchange protein, AE1. J Biol Chem 274: 6626–6633, 1999.[Abstract/Free Full Text]

10. Funder J, Wieth JO. Chloride transport in human erythrocytes and ghosts: a quantitative comparison. J Physiol 262: 679–698, 1976.[Abstract/Free Full Text]

11. Gawenis LR, Ledoussal C, Judd LM, Prasad V, Alper SL, Stuart-Tilley A, Woo AL, Grisham C, Sanford LP, Doetschman T, Miller ML, Shull GE. Mice with a targeted disruption of the AE2 Cl/HCO3 exchanger are achlorhydric. J Biol Chem 279: 30531–30539, 2004.[Abstract/Free Full Text]

12. Grinstein S, Ship S, Rothstein A. Anion transport in relation to proteolytic dissection of band 3 protein. Biochim Biophys Acta 507: 294–304, 1978.[Medline]

13. Hamasaki N, Izuhara K, Okubo K, Kanazawa Y, Omachi A, Kleps RA. Inhibition of chloride binding to the anion transport site by diethylpyrocarbonate modification of band 3. J Membr Biol 116: 87–91, 1990.[CrossRef][Web of Science][Medline]

14. Hentschke M, Wiemann M, Hentschke S, Kurth I, Hermans-Borgmeyer I, Seidenbecher T, Jentsch TJ, Gal A, Hubner CA. Mice with a targeted disruption of the Cl/HCO3 exchanger AE3 display a reduced seizure threshold. Mol Cell Biol 26: 182–191, 2006.[Abstract/Free Full Text]

15. Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77: 61–68, 1989.[CrossRef][Web of Science][Medline]

16. Hu J, Fu R, Nishimura K, Zhang L, Zhou HX, Busath DD, Vijayvergiya V, Cross TA. Histidines, heart of the hydrogen ion channel from influenza A virus: toward an understanding of conductance and proton selectivity. Proc Natl Acad Sci USA 103: 6865–6870, 2006.[Abstract/Free Full Text]

17. Humphreys BD, Jiang L, Chernova MN, Alper SL. Functional characterization and regulation by pH of murine AE2 anion exchanger expressed in Xenopus oocytes. Am J Physiol Cell Physiol 267: C1295–C1307, 1994.[Abstract/Free Full Text]

18. Izuhara K, Okubo K, Hamasaki N. Conformational change of band 3 protein induced by diethyl pyrocarbonate modification in human erythrocyte ghosts. Biochemistry 28: 4725–4728, 1989.[CrossRef][Medline]

19. Jiang L, Stuart-Tilley A, Parkash J, Alper SL. pHi and serum regulate AE2-mediated Cl/HCO3 exchange in CHOP cells of defined transient transfection status. Am J Physiol Cell Physiol 267: C845–C856, 1994.[Abstract/Free Full Text]

20. Jin XR, Abe Y, Li CY, Hamasaki N. Histidine-834 of human erythrocyte band 3 has an essential role in the conformational changes that occur during the band 3-mediated anion exchange. Biochemistry 42: 12927–12932, 2003.[CrossRef][Medline]

21. Kopito RR, Lee BS, Simmons DM, Lindsey AE, Morgans CW, Schneider K. Regulation of intracellular pH by a neuronal homolog of the erythrocyte anion exchanger. Cell 59: 927–937, 1989.[CrossRef][Web of Science][Medline]

22. Kurz LL, Klink H, Jakob I, Kuchenbecker M, Benz S, Lehmann-Horn F, Rudel R. Identification of three cysteines as targets for the Zn2+ blockade of the human skeletal muscle chloride channel. J Biol Chem 274: 11687–11692, 1999.[Abstract/Free Full Text]

23. Lee BS, Gunn RB, Kopito RR. Functional differences among nonerythroid anion exchangers expressed in a transfected human cell line. J Biol Chem 266: 11448–11454, 1991.[Abstract/Free Full Text]

24. Leem CH, Vaughan Jones RD. Sarcolemmal mechanisms for pHi recovery from alkalosis in the guinea-pig ventricular myocyte. J Physiol 509: 487–496, 1998.[Abstract/Free Full Text]

25. Li C, Moore DS, Rosenberg RC. Circular dichroism studies of diethyl pyrocarbonate-modified histidine in hen egg white lysozyme. J Biol Chem 268: 11090–11096, 1993.[Abstract/Free Full Text]

26. Liu Y, Teeter MM, DuRand CJ, Neve KA. Identification of a Zn2+-binding site on the dopamine D2 receptor. Biochem Biophys Res Commun 339: 873–879, 2006.[CrossRef][Web of Science][Medline]

27. Lundblad R, Noyes C. Chemical Reagents for Protein Modification. Boca Raton, FL: CRC, 1984.

28. Meves H. Slowing of ERG current deactivation in NG108-15 cells by the histidine-specific reagent diethylpyrocarbonate. Neuropharmacology 41: 220–228, 2001.[CrossRef][Web of Science][Medline]

29. Miles EW. Modification of histidyl residues in proteins by diethylpyrocarbonate. Methods Enzymol 47: 431–442, 1977.[Medline]

30. Morton MJ, Abohamed A, Sivaprasadarao A, Hunter M. pH sensing in the two-pore domain K+ channel, TASK2. Proc Natl Acad Sci USA 102: 16102–16106, 2005.[Abstract/Free Full Text]

31. Muller-Berger S, Karbach D, Kang D, Aranibar N, Wood PG, Ruterjans H, Passow H. Roles of histidine 752 and glutamate 699 in the pH dependence of mouse band 3 protein-mediated anion transport. Biochemistry 34: 9325–9332, 1995.[CrossRef][Medline]

32. Muller-Berger S, Karbach D, Konig J, Lepke S, Wood PG, Appelhans H, Passow H. Inhibition of mouse erythroid band 3-mediated chloride transport by site-directed mutagenesis of histidine residues and its reversal by second site mutation of Lys 558, the locus of covalent H2DIDS binding. Biochemistry 34: 9315–9324, 1995.[CrossRef][Medline]

33. Nemeth-Cahalan KL, Hall JE. pH and calcium regulate the water permeability of aquaporin 0. J Biol Chem 275: 6777–6782, 2000.[Abstract/Free Full Text]

34. Nemeth-Cahalan KL, Kalman K, Hall JE. Molecular basis of pH and Ca2+ regulation of aquaporin water permeability. J Gen Physiol 123: 573–580, 2004.[Abstract/Free Full Text]

35. Reinertsen KV, Tonnessen TI, Jacobsen J, Sandvig K, Olsnes S. Role of chloride/bicarbonate antiport in the control of cytosolic pH. Cell-line differences in activity and regulation of antiport. J Biol Chem 263: 11117–11125, 1988.[Abstract/Free Full Text]

36. Sekler I, Lo RS, Kopito RR. A conserved glutamate is responsible for ion selectivity and pH dependence of the mammalian anion exchangers AE1 and AE2. J Biol Chem 270: 28751–28758, 1995.[Abstract/Free Full Text]

37. Stewart AK, Chernova MN, Kunes YZ, Alper SL. Regulation of AE2 anion exchanger by intracellular pH: critical regions of the NH2-terminal cytoplasmic domain. Am J Physiol Cell Physiol 281: C1344–C1354, 2001.[Abstract/Free Full Text]

38. Stewart AK, Chernova MN, Shmukler BE, Wilhelm S, Alper SL. Regulation of AE2-mediated Cl transport by intracellular or by extracellular pH requires highly conserved amino acid residues of the AE2 NH2-terminal cytoplasmic domain. J Gen Physiol 120: 707–722, 2002.[Abstract/Free Full Text]

39. Stewart AK, Kerr N, Chernova MN, Alper SL, Vaughan-Jones RD. Acute pH-dependent regulation of AE2-mediated anion exchange involves discrete local surfaces of the NH2-terminal cytoplasmic domain. J Biol Chem 279: 52664–52676, 2004.[Abstract/Free Full Text]

40. Varadaraj K, Kumari S, Shiels A, Mathias RT. Regulation of aquaporin water permeability in the lens. Invest Ophthalmol Vis Sci 46: 1393–1402, 2005.[Abstract/Free Full Text]

42. Wang D, Balkovetz DF, Warnock DG. Mutational analysis of transmembrane histidines in the amiloride-sensitive Na+/H+ exchanger. Am J Physiol Cell Physiol 269: C392–C402, 1995.[Abstract/Free Full Text]

43. Wiebe CA, Rieder C, Young PG, Dibrov P, Fliegel L. Functional analysis of amino acids of the Na+/H+ exchanger that are important for proton translocation. Mol Cell Biochem 254: 117–124, 2003.[CrossRef][Web of Science][Medline]

44. Yeh BI, Sun TJ, Lee JZ, Chen HH, Huang CL. Mechanism and molecular determinant for regulation of rabbit transient receptor potential type 5 (TRPV5) channel by extracellular pH. J Biol Chem 278: 51044–51052, 2003.[Abstract/Free Full Text]

45. Zhang D, Kiyatkin A, Bolin JT, Low PS. Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3. Blood 96: 2925–2933, 2000.[Abstract/Free Full Text]

46. Zhang Y, Chernova MN, Stuart-Tilley AK, Jiang L, Alper SL. The cytoplasmic and transmembrane domains of AE2 both contribute to regulation of anion exchange by pH. J Biol Chem 271: 5741–5749, 1996.[Abstract/Free Full Text]

47. Zhu Q, Lee DW, Casey JR. Novel topology in C-terminal region of the human plasma membrane anion exchanger, AE1. J Biol Chem 278: 3112–3120, 2003.[Abstract/Free Full Text]

48. Zolotarev AS, Shmukler BE, Alper SL. AE2 anion exchanger polypeptide is a homooligomer in pig gastric membranes: a chemical cross-linking study. Biochemistry 38: 8521–8531, 1999.[CrossRef][Medline]




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
M. N. Chernova, A. K. Stewart, P. N. Barry, M. L. Jennings, and S. L. Alper
Mouse Ae1 E699Q mediates SO42-i/aniono exchange with [SO42-]i-dependent reversal of wild-type pHo sensitivity
Am J Physiol Cell Physiol, August 1, 2008; 295(2): C302 - C312.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. K. Stewart, C. E. Kurschat, R. D. Vaughan-Jones, B. E. Shmukler, and S. L. Alper
Acute regulation of mouse AE2 anion exchanger requires isoform-specific amino acid residues from most of the transmembrane domain
J. Physiol., October 1, 2007; 584(1): 59 - 73.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Figures and Table
Right arrow All Versions of this Article:
292/2/C909    most recent
00265.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stewart, A. K.
Right arrow Articles by Alper, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stewart, A. K.
Right arrow Articles by Alper, S. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.